FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews
In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF
NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget
FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available
DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation
DCE Technical Support Contracts Recompetition Approved in Concept
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Benjamin Ebert, Amy Gladfelter, Stephen Liberles, and Pardis Sabeti are among new members of the National Academy of Sciences









